JPMorgan Upgrades IBM to Overweight, Raises Target to $291
JPMorgan's Brian Essex upgraded IBM to Overweight from Neutral and raised the price target to $291 from $270, noting that software generates roughly two-thirds of profit while accounting for only 45% of revenue, justifying a higher multiple.
Key Numbers
Shares of technology and consulting giant IBM (NYSE:IBM) jumped 4.3% in afternoon trading after JPMorgan analyst Brian Essex upgraded the stock to Overweight from Neutral and raised his price target to $291 from $270, implying approximately 15% upside.
Rating Change
- Previous Rating: Neutral
- New Rating: Overweight
- Previous Target: $270
- New Target: $291
- Implied Upside: ~15%
Analyst's Rationale
Essex believes IBM's shift toward software justifies a higher valuation multiple. Although software accounts for only about 45% of revenue, it generates roughly two-thirds of consolidated profit. This profit mix shift, in his view, supports an elevated multiple.
Context
The upgrade comes as IBM continues to pivot toward cloud computing and artificial intelligence. No other analysts have issued similar calls yet. The stock has been volatile over the past month but currently trades near $250.
What to Make of It
JPMorgan's upgrade reflects growing confidence in IBM's strategy to focus on high-margin software and services. However, investors should monitor the company's execution and its impact on future growth.
Frequently Asked Questions
Found this useful? Share it